Miri Yavzori

Optimizing Anti-TNF-α Therapy: Serum Levels of Infliximab and Adalimumab Are Associated With Mucosal Healing in Patients With Inflammatory Bowel Diseases

Bella Ungar, Idan Levy, Yarden Yavne et al. · Clinical Gastroenterology and Hepatology · 2015 · 360 citations

Inflammation, Rheumatology, Mucosal Healing +12

Addition of an Immunomodulator to Infliximab Therapy Eliminates Antidrug Antibodies in Serum and Restores Clinical Response of Patients With Inflammatory Bowel Disease

Shomron Ben‐Horin, Matti Waterman, Uri Kopylov et al. · Clinical Gastroenterology and Hepatology · 2012 · 302 citations

Inflammation, Chronic Inflammatory Diseases, Anti-inflammatory +10

The temporal evolution of antidrug antibodies in patients with inflammatory bowel disease treated with infliximab

Bella Ungar, Yehuda Chowers, Miri Yavzori et al. · Gut · 2013 · 298 citations

Double-blind vaccine-controlled randomised efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults

Dani Cohen, Shai Ashkenazi, Manfred S. Green et al. · The Lancet · 1997 · 258 citations

Vaccination, Vaccine Safety, Cross-protection +6

The immunogenic part of infliximab is the F(ab')2, but measuring antibodies to the intact infliximab molecule is more clinically useful

Shomron Ben‐Horin, Miri Yavzori, Lior H. Katz et al. · Gut · 2010 · 204 citations